Clinical Trials Directory
Our Duke Health and Exercise Research Trials Registry is a way for people to let our team know that they are interested in learning more about any of our studies for which they may qualify.
Our studies include both healthy people and those who may have certain medical conditions.
We created the Duke Clinical Research Volunteer Registry for people who would like to join clinical research studies. We will use this registry to contact you about available studies.
For more information or to sign up, visit us at:
https://redcap.duke.edu/redcap/surveys/?s=X4T7JKHPX4
A registry is a database of information (data) about patients living with a specific condition. Scientists study the information in the registry to increase what we know about the condition so we can develop better treatments in the future.
This registry will help us better understand lupus and how it is managed, including how different treatments work and their long-term safety.
We have created this repository (storehouse) as a way to securely store your data and samples for future research studies.
These data and samples help us to learn more about health, injury and disease that we hope will lead to improved care of patients.
We are doing this study to learn about how many patients with dysphagia go to surgical clinics and see how it effects their operation and recovery.
We are doing this study to compare the safety and effects of stopping the standard melanoma treatments of nivolumab + pembrolizumab or nivolumab + relatlimab at different times. We hope this study will help us discover certain markers from imaging and biopsies that can signal when it is the appropriate time to stop therapy.
We are doing this study to find out whether an autotransplant improves survival in mantle cell lymphoma patients who have achieved an excellent (minimal residual disease-negative) first complete remission (CR).
We are doing this study to find out what effects anti-inflammatory injections have on the blood glucose levels of patients with diabetes.